Granisetron in pharma franchise in Bihar

Granisetron in PCD pharma franchise in Patna

Granisetron in top pharma company in Lucknow

Granisetron in pcd pharma supplier in Kanpur

Granisetron in phama franchise company in India
Granisetron in phama distributor in Jaipur

Home/Products /granisetron-1mg-injection

Granityle Injection

Composition : Granisetron (1mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 3mg/3ml

Price : ₹111/-

Granityle Injection (Granisetron 1mg) is a potent antiemetic medication specifically formulated to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgical procedures. Granisetron, the active ingredient in Granityle, belongs to a class of drugs known as 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a neurotransmitter involved in triggering nausea and vomiting. By inhibiting the serotonin receptors in the brain and gastrointestinal tract, Granityle helps to prevent the onset of nausea and vomiting that often accompanies medical treatments such as chemotherapy or major surgeries.

This medication is commonly used in oncology settings, particularly in patients undergoing chemotherapy for cancer, as well as in individuals who experience postoperative nausea and vomiting. It is effective in providing relief from these symptoms, which can severely affect the quality of life and delay recovery. The injection is typically administered under the supervision of a healthcare professional in a clinical setting.

Read More

About the Product

Granityle Injection (Granisetron 1mg) is a potent antiemetic medication specifically formulated to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgical procedures. Granisetron, the active ingredient in Granityle, belongs to a class of drugs known as 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a neurotransmitter involved in triggering nausea and vomiting. By inhibiting the serotonin receptors in the brain and gastrointestinal tract, Granityle helps to prevent the onset of nausea and vomiting that often accompanies medical treatments such as chemotherapy or major surgeries.

This medication is commonly used in oncology settings, particularly in patients undergoing chemotherapy for cancer, as well as in individuals who experience postoperative nausea and vomiting. It is effective in providing relief from these symptoms, which can severely affect the quality of life and delay recovery. The injection is typically administered under the supervision of a healthcare professional in a clinical setting.

Common side effects include headache, constipation, dizziness, and mild injection site reactions. Serious side effects may include allergic reactions or irregular heartbeat. Seek medical attention if these occur.

Granityle Injection is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiation therapy, or surgery.

Granityle Injection should only be used under the supervision of a healthcare professional. Consult your doctor before use if you have any known allergies or medical conditions.

Store Granityle Injection at room temperature in a cool, dry place, away from direct sunlight. Keep the vial tightly sealed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation